Dengue: Recent Trends
Keywords:
Dengue, Recent trends, Dengue hemorrhagic fever
Abstract
Today dengue ranks as the most important mosquito-borne viral disease in the world & its incidence has increased 30-fold over the last 50 years. In India there is recent increase in cases of Dengue in last few years.
Downloads
Download data is not yet available.
References
1. Chakravarti A, Kumaria R. Eco-epidemiological analysis of dengue infection during an outbreak of dengue fever, India. Virol J 2005;2:32. [PubMed]
2. Singhasivanon P, Jacobson J. Foreward. J ClinVirol2009; 46 (Sup 2): S1- S2. [PubMed]
3. Ginsberg J, Mohebbi MH, Patel RS, Brammer L, Smolinski MS, Brilliant L. Detecting influenze epidemics using search engine query data. Nature 2008;457:1012–1014. [PubMed]
4. Toledo ME, Rodrigues A, Valdes L, Carrion R, Cabrera G, Banderas D, et al. Evidence on impact of community-based environmental management on dengue transmission in Santiago deCuba. Trop Med Int Health 2011; 16: 744-747. [PubMed]
5. Robertson C, Nelson TA (2010) Review of software for space-time disease surveillance. Int J Health Geogr 9: 9–16. [PubMed]
6. Kitchener S, Nissen M, Nasveld P, Forrat R, Yoksan S, Lang J, Saluzzo JF. Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults. Vaccine 2006; 24(9):1238-1241. [PubMed]
7. Guirakhoo F, Kitchener S, Morrison D, etal. Live attenuated chimeric yellow fever dengue type 2 (ChimerVax- DEN2) vaccine: phase I clinical trial for safety and immunogenicity in induction of cross neutralizing antibody responses to all 4 dengue serotypes. Hum Vaccin 2006; 2: 60-67.
2. Singhasivanon P, Jacobson J. Foreward. J ClinVirol2009; 46 (Sup 2): S1- S2. [PubMed]
3. Ginsberg J, Mohebbi MH, Patel RS, Brammer L, Smolinski MS, Brilliant L. Detecting influenze epidemics using search engine query data. Nature 2008;457:1012–1014. [PubMed]
4. Toledo ME, Rodrigues A, Valdes L, Carrion R, Cabrera G, Banderas D, et al. Evidence on impact of community-based environmental management on dengue transmission in Santiago deCuba. Trop Med Int Health 2011; 16: 744-747. [PubMed]
5. Robertson C, Nelson TA (2010) Review of software for space-time disease surveillance. Int J Health Geogr 9: 9–16. [PubMed]
6. Kitchener S, Nissen M, Nasveld P, Forrat R, Yoksan S, Lang J, Saluzzo JF. Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults. Vaccine 2006; 24(9):1238-1241. [PubMed]
7. Guirakhoo F, Kitchener S, Morrison D, etal. Live attenuated chimeric yellow fever dengue type 2 (ChimerVax- DEN2) vaccine: phase I clinical trial for safety and immunogenicity in induction of cross neutralizing antibody responses to all 4 dengue serotypes. Hum Vaccin 2006; 2: 60-67.
CITATION
DOI: 10.17511/ijmrr.2015.i8.169
Published: 2015-09-30
How to Cite
1.
Chandran R, Gedam DS. Dengue: Recent Trends. Int J Med Res Rev [Internet]. 2015Sep.30 [cited 2024Nov.8];3(8):781-2. Available from: https://ijmrr.medresearch.in/index.php/ijmrr/article/view/321
Section
Editorial
OAI - Open Archives Initiative
